Congo vs Tunisia: Access to anti-retroviral drugs, female
Congo
33.0%
in 2024
Tunisia
33.0%
in 2024
Congo rank
133rd
Tunisia rank
133rd
Access to anti-retroviral drugs, female over time
- Congo
- Tunisia
How they compare
Congo currently reports 33.0% against 33.0% in Tunisia, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Tunisia ahead.
Congo ranks 133rd and Tunisia ranks 133rd of 141 countries.
Across the 3 decades both report, Congo averaged higher in 1 and Tunisia in 2.
Head to head by decade
| Decade | Congo | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.1% | 4.4% | 1.3% | Tunisia |
| 2010s | 21.0% | 19.9% | 1.1% | Congo |
| 2020s | 28.2% | 33.8% | 5.6% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Congo or Tunisia?
- Congo, at 33.0% against 33.0% in Tunisia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Congo and Tunisia?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo and Tunisia rank globally for access to anti-retroviral drugs, female?
- Congo ranks 133rd and Tunisia ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.